AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 251 min read$CRDO

Cheng Chi Fung sold $5.3M of CRDO (indirect holdings)

Cheng Chi Fung (Chief Technology Officer) sold 27,500 indirectly-held shares of Credo Technology Group Holding Ltd (CRDO) at an average of $193.12 ($190.03–$195.68, $5.31M total) across 7 trades on 2026-09-23 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cheng Chi Fung
Published Sep 25, 2026, 8:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 8:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CRDO
Bearish
medium confidence
Mentioned
$CRDO
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CRDOBearishMed
01

Why it matters

The sale reduces insider ownership and may be interpreted as a lack of confidence, prompting short interest.

02

Market read

Primary insider sale news; modest materiality for traders monitoring biotech equities.

03

What to watch

Potential upcoming catalyst (e.g., trial data) that insiders are positioning for.

Relevance 5/10Novelty 8/10Timing: post‑market 2026‑09‑23

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the CTO's sale.

Company-level read

Ticker impact

$CRDOBearishMedium confidence
Context

Chief Technology Officer sold 27,500 shares for $5.3M via a 10b5-1 plan, reducing his stake to 5.69M shares.

Expected impact

Potential short-term downside pressure of 2‑4% as the market digests the sale.

Evidence & confidence

A $5.3M sale by a senior officer is material for a mid‑cap biotech, and the 10b5‑1 plan suggests pre‑planned execution rather than panic, limiting the impact but still negative.

Market effects

Sector

May raise concerns for other biotech firms with insider sell activity.

Regional

Limited to U.S. biotech sector, no broader regional effect.

Global

Low; impact confined to CRDO and its immediate peers.

Counterpoint

What could challenge this read

The sale could be purely execution of a pre‑arranged plan, not a bearish signal.

Key entities

  • Company
    Credo Technology Group Holding Ltd

    Biotech firm listed on Nasdaq under CRDO.

  • Individual
    Cheng Chi Fung

    Chief Technology Officer and insider selling shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CRDO insider trading history →

Related articles

SEP 21
$CRDOMed

Why is Credo Technology stock rallying today?

Credo Technology (CRDO) shares rose 6.0% to $186.49 after analysts highlighted its optical networking solutions at ECOC 2026. Mizuho maintained an Outperform rating, lowering its target to $245, while Rosenblatt initiated coverage with a Buy and a $235 target. The stock trades 43% below its 52-week high despite 115% revenue growth, with consensus targets implying 61% upside.

investing.com2 min
SEP 17
$CRDOMed

What's Going On With Credo Technology Stock on Thursday?

Credo Technology (CRDO) shares rose 4% in premarket trading on Thursday. The company launched its 224G-based ZeroFlap optical transceiver family for AI networking, a key step in its roadmap. Credo reported Q1 2027 revenue of $479M, beating estimates, with CEO Bill Brennan highlighting AI infrastructure as a growth driver. Analysts maintain a Buy rating with an average price target of $273.07.

aol.com2 min
SEP 15
$CRDOMedAI 8/10

Credo vs. Broadcom: Which AI Connectivity Stock Is the Better Pick?

Credo (CRDO) and Broadcom (AVGO) are both benefiting from the AI infrastructure boom. Credo reported Q1 revenues of $479M, up 115% YoY, with strong growth in optical and AEC segments. Broadcom saw Q3 revenues of $29.59B, up 85.5% YoY, with AI semiconductors representing 56% of total revenue. Both companies show strong growth but face risks like customer concentration and execution challenges.

finance.yahoo.com2 min